Surgery
Volume 146, Issue 6 , Pages 1182-1187 , December 2009

Does failure to perform prophylactic level VI node dissection leave persistent disease detectable by ultrasonography in patients with low-risk papillary carcinoma of the thyroid?

,Accepted 5 October 2009.

References 

  1. Sherman SI. Thyroid carcinoma. Lancet. 2003;361:501–511
  2. Machens A, Hinze R, Thomusch O, Dralle H. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg. 2002;26:22–28
  3. Grodski S, Cornford L, Sywak M, Sidhu S, Delbridge L. Routine level VI lymph node dissection for papillary thyroid cancer: surgical technique. ANZ J Surg. 2007;77:203–208
  4. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16:109–142
  5. White ML, Gauger PG, Doherty GM. Central lymph node dissection in differentiated thyroid cancer. World J Surg. 2007;31:895-04
  6. Swyak M, Cornford L, Roach P, Stalberg P, Sidhu S, Delbridge L. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery. 2006;140:1000–1007
  7. Hay ID, McConahey WM, Goellner JR. Managing patients with papillary thyroid carcinoma. Insights gained from the May Clinic's experience of treating 2,512 consecutive patients during 1940-2000. Trans Amer Clin Climatol Assoc. 2002;113:241–260
  8. Kouvaraki MA, Shapiro SE, Fornage BD, Edelken-Monro Sherman SI, Vassilopoulou-Sellin R, et al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery. 2003;134:946–954
  9. Musacchio MJ, Kim AW, Visungco JD, Prinz RA. Greater local recurrences occurs with “berry picking” then neck dissection in thyroid cancer. Am Surg. 2003;69:191–196
  10. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295:2164–2167
  11. Hay ID, Hutchinson ME, Gonzalez-Losanda McIver B, Reinalda ME, et al. Papillary microcarcinoma: a study of 900 cases observed in a 6-year period. Surgery. 2008;114:980–988
  12. Hay ID. Management of patients with low-risk papillary thyroid carcinoma. Endocr Pract. 2007;13:521–533
  13. Henry JF, Gramatica L, Denizot A, Kvachenyuk A, Puccini M, Defechereux T. Morbidity of prophylacticlymph node dissection in the central neck area in patients with papillary thyroid carcinoma. Langenbecks Arch Surg. 1998;383:167–169
  14. Dupuy DE, Monchik JM, Decrea C, Pisharodi L. Radiofrequency ablation of regional recurrence from well differentiated thyroid malignancy. Surgery. 2001;130:371–377
  15. Monchik JM, Donatini G, Iannucilli J, Dupuy DE. Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg. 2006;244:296–304

PII: S0039-6060(09)00634-5

doi: 10.1016/j.surg.2009.10.024

Surgery
Volume 146, Issue 6 , Pages 1182-1187 , December 2009

Article Tools

* Image Usage & Resolution